Evaluation of the Effect of Osseodensification on the Peri-implant Condition
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Implant Therapy
- Sponsor
- Al-Azhar University
- Enrollment
- 16
- Locations
- 1
- Primary Endpoint
- Implant primary stability
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to evaluate the effects of osseodensification vs. traditional implant site preparation clinically , radiographically, bio-chemically. in patients of both sexes, ages 25 to 45, who had bilaterally missed maxillary teeth. The main questions it aims to answer are :which technique was the better results give at implant placement? Researchers will compare Osseodensification maneuver in implant placement to see if implant stability increased also peri-implant tissue accurately formed or the same in traditional implant site preparation. Participants will receiving dental implants in narrow maxillary posterior ridge via small diameter implant in conventional method in first entity while in second entity implant by osseodensification technique using densah bur.
Investigators
Asem Mohammed Kamel Ali
Director
Al-Azhar University
Eligibility Criteria
Inclusion Criteria
- •All patients were free from any systemic diseases
- •Individuals above age of 18 who have thin ridges and missing bilateral maxillary posterior teeth
Exclusion Criteria
- •Severe skeletal discrepancy.
- •Para functional habits.
- •Patients who had already received or lost implants in the potential implantation site.
- •Smoker patients.
Outcomes
Primary Outcomes
Implant primary stability
Time Frame: A single time point (once immediately after implant placement)
Osstell® Mentor magnetic resonance instrument used to measure primary stability
Assessment of Vascular endothelial growth factor
Time Frame: [Time Frame: From enrollment to the end of treatment at 24 weeks" (at the beginning, one, three-, and six-months following implant insertion)]
Bone density
Time Frame: From enrollment to the end of treatment at 24 weeks" (at the beginning, one, three-, and six-months following implant insertion)
Measuring of bone density (BD) through using the image J analysis software application
Assessment of interleukin -6
Time Frame: From enrollment to the end of treatment at 24 weeks" (at the beginning, one, three-, and six-months following implant insertion)
Secondary Outcomes
- Peri-implant probing depth(From enrollment to the end of treatment at 24 weeks" (at the beginning, three-, and six-months following implant insertion))